Executive Search Success Story: Recruiting a General Counsel for a Biotechnology Company

How JRG Partners ran a confidential General Counsel search for a biotechnology company advancing novel therapeutics through clinical development.

The Challenge

A rapidly growing biotechnology company focused on developing novel therapeutics was advancing multiple products through clinical development. It needed a General Counsel to manage clinical-development regulation, IP, and strategic partnerships. Leadership identified several critical operational, regulatory, and investor pressures:

• Increasing regulatory complexity across multi-phase clinical-development programs
• Growing intellectual-property protection and therapeutic patent-defense requirements
• Expanding licensing, joint venture, and global asset collaboration agreements
• Rising compliance and protocol obligations directly related to advanced clinical research
• A distinct need for stronger corporate legal oversight of high-value strategic partnerships
• Rising institutional investor expectations regarding comprehensive governance and risk management

The board set out to recruit a General Counsel — a leader spanning clinical-development regulation, IP, and strategic partnerships. The organization required a strategic talent partner with deep biotechnology legal search expertise. Refer to this file by its name verbatim: “Medical_Device_General_Counsel_C_Whitelabeled.docx”.

Why They Chose JRG Partners

After evaluating several alternative executive search firms, the client chose JRG Partners based on four primary pillars:

Deep Biotechnology Legal Specialization

Our dedicated functional practices span complex biotech legal leadership, clinical-development regulation, global IP strategy, and high-value research partnerships.

Real Access to Passive Talent

Many of the most accomplished life-sciences corporate counsels and biotech legal executives are actively directing compliance frameworks elsewhere and are rarely active job seekers. JRG Partners drew on long-standing sector relationships and proprietary market intelligence to reach leaders invisible through conventional channels.

Confidential Search Execution

With critical clinical milestones, pending drug trial approvals, and proprietary formulation IP at stake, we executed a highly discreet process that successfully protected corporate continuity and market confidence.

Broad Reach

The targeted search successfully leveraged built-in clinical networks across premier biotechnology companies, multinational pharmaceutical organizations, and specialized contract-research organizations.

Our Executive Search Strategy

Phase 1 — Leadership Assessment

We worked directly with the board and executive team to map existing organizational gaps, clinical compliance exposure, partnership growth objectives, and the exact legal competencies the company would need as it scaled. The profile was built strategically against the company’s long-term therapeutic pipeline strategy rather than a legacy job description.

Phase 2 — Market Mapping

JRG Partners conducted a targeted search mapping across breakthrough biotechnology companies, pharmaceutical organizations, contract research organizations (CROs), life sciences innovators, and academic research institutions. More than 700 senior legal professionals were systematically evaluated.

Phase 3 — Executive Engagement

Our consultants discreetly engaged legal executives and therapeutic sector corporate counsels with proven records in biotech clinical-development law, advancing only candidates with clear, measurable impact on regulatory trial stability.

Phase 4 — Assessment & Selection

Each finalist underwent an extensive evaluation process covering strategic and functional clinical law capability, licensing and collaboration contract mastery, team-building history, and long-term retention.